Drug intelligence / Profile preview

Merita

Development stage
Unknown
Lead developer
Enactis Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Merita is a nutraceutical supplement developed and manufactured by Enactis Healthcare, primarily available in the Indian market. It is formulated as oral capsules containing a combination of 500 mg of tetrahydrocurcuminoids and 5 mg of piperine (95% purity). Tetrahydrocurcuminoids are the primary active metabolites of curcumin, offering superior stability and antioxidant potency compared to the parent compound. They exert anti-inflammatory effects by modulating key signaling pathways, such as the inhibition of cyclooxygenase-2 (COX-2) and nuclear factor-kappa B (NF-κB). Piperine, an alkaloid derived from black pepper, is included to enhance the systemic bioavailability of the curcuminoids by inhibiting metabolic enzymes like CYP3A4 and UDP-glucuronosyltransferases. Merita is marketed for its antioxidant and anti-inflammatory properties, with applications in supporting joint health, digestive function, cardiovascular health, and cognitive performance.

Brand names
Merita
02

Targets

NF-κBPTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Merita.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Merita.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call